|
Volumn 29, Issue 2, 2004, Pages 8-21
|
Drug approval highlights for 2003
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
CARDIOVASCULAR AGENT;
DERMATOLOGICAL AGENT;
DRUG DERIVATIVE;
IMMUNOLOGIC FACTOR;
MANDELIC ACID DERIVATIVE;
OXYBUTYNIN;
VALACICLOVIR;
VALINE;
CARDIOVASCULAR DISEASE;
DRUG APPROVAL;
ESTROGEN THERAPY;
FEMALE;
GENITAL SYSTEM DISEASE;
GYNECOLOGIC DISEASE;
HUMAN;
INSTRUMENTATION;
MALE;
REVIEW;
SKIN DISEASE;
WOMEN'S HEALTH;
ACYCLOVIR;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
DERMATOLOGIC AGENTS;
DRUG APPROVAL;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
GENITAL DISEASES, FEMALE;
GENITAL DISEASES, MALE;
HUMANS;
IMMUNOLOGIC FACTORS;
MALE;
MANDELIC ACIDS;
SKIN DISEASES;
VALINE;
WOMEN'S HEALTH;
|
EID: 2342435060
PISSN: 03611817
EISSN: 15388662
Source Type: Journal
DOI: 10.1097/00006205-200402000-00002 Document Type: Article |
Times cited : (5)
|
References (0)
|